Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): A pilot trial
(silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial
To assess systemic toxicity, tumor-free NMRI mice were treated orally with NXP800 (35 mg/kg, 5 days/week for 2 weeks
If you are new to the topic, start with our guide to methylation and homocysteine first
Abstract Type 2 diabetes represents a growing challenge for global public health
Cost and access represent significant practical considerations for long-term therapy
US$ 24.66
US$ 27.23
US$ 25.17
US$ 26.64
